Market Expansion Sientra's recent launch of high-strength cohesive silicone gel breast implants in Canada indicates an opportunity to target international markets with innovative and FDA-approved products, potentially increasing sales through geographic expansion.

Product Portfolio Growth The company's focus on advanced breast implant technology, including dual-port tissue expanders and fat transfer innovations, creates avenues for upselling and cross-selling to plastic surgeons seeking state-of-the-art solutions.

Acquisition Opportunities With Sientra selling major assets to Tiger Aesthetics and other entities, there may be opportunities to acquire or partner on remaining innovations, licenses or related technologies that can be integrated into existing product lines.

Operational Restructuring Recent facility closures and workforce reductions suggest a transitional phase that could open doors to strategic collaborations with new management or restructuring consultants to optimize sales channels and distribution.

Potential Customer Base Given their specialization in innovative, high-quality breast and tissue expansion products, targeting plastic surgeons and aesthetic clinics investing in cutting-edge treatments presents a significant sales opportunity for premium medical equipment.